Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: Focus on clinical trials and perspectives

This publication has 65 references indexed in Scilit:

• A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer
  European Journal Of Cancer, 2006
• Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
  British Journal of Cancer, 2006
• The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers
  Breast Cancer Research and Treatment, 2006
• Advances in Adjuvant Hormonal Therapy for Postmenopausal Women
  Journal of Clinical Oncology, 2005
• A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
  Breast Cancer Research and Treatment, 2005
• Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy
  Endocrine-Related Cancer, 2004
• Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation
  Journal of Biological Chemistry, 2003
• Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene
  Endocrinology, 1996
• Aberrant function of the Ras signal transduction pathway in human breast cancer
  Breast Cancer Research and Treatment, 1995
• Evaluation of epidermal growth factor receptor occupency by EGF-like peptide in 55 breast and 42 non breast tumor biopsies
  European Journal of Cancer and Clinical Oncology, 1990